Moreover, PURA has been demonstrated to regulate MBP gene transcription [43] and, under particular immunosuppressive conditions, into the demyelinating disease named progressive multifocal leukoencephalopathy, which precisely consists in the degeneration of the oligodendroglial cells [44]. The gene discussed is MBP; the disease is demyelinating disease.